Symbicort Rapihaler
Brand Name: Symbicort Rapihaler
Generic Name: Budesonide + Formoterol fumarate dihydrate
Active
Registration Number
DR-XY45700
Dosage Form
Inhalation Aerosol (Pressurized Suspension for Inhalation)
Issuance Date
March 28, 2022
Expiry Date
December 9, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength80 mcg/4.5 mcg per Actuation
PackagingPressurized Metered Dose Inhaler with a
Perfluoroalkoxy (PFA) Polymer Internally Coated Anodised Aluminum Can Sealed with a Retention Type Metering Valve Wrapped in a Foil Pouch with Dessicant Sachet x 120 Actuations (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergics and Other Drugs for Obstructive Airway
Disease
A
Application
Initial
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
BudesonideActive
Monograph: Budesonide
Formoterol fumarate dihydrateActive
Monograph: Aluminum sulfate